PET scan study for early active systemic sclerosis
Part of Skin clinical trials.
This trial uses PET/CT scans with special tracers to look at inflammation and activity in systemic sclerosis (scleroderma) soon after symptoms begin. It may help researchers understand what’s driving active disease and where it shows up in the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re an adult with active systemic sclerosis (SSc).
- Your first non–Raynaud symptom started within the last 5 years.
- Your disease is considered active, based on nailfold blood vessel changes and/or higher inflammation blood tests (CRP or ESR).
- You have no other autoimmune disease or inflammatory joint disease besides systemic sclerosis.
- You have not used most immune-suppressing medicines or biologic medicines before starting the study (some limits apply).
- You have not had recent steroid shots by mouth/injection or certain blood-vessel medications within 4 weeks before the scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental cell therapy that targets your own immune cells to treat systemic sclerosis (scleroderma) with lung involvement. It aims to see if this treatment works better than standard care in reducing disease activity.
This trial tests a new cell injection treatment (RY_SW01) for people with systemic sclerosis (a condition causing skin thickening and organ issues). It aims to see if the therapy can improve skin hardening and overall symptoms.
This early-stage trial tests an investigational cell therapy for people with systemic sclerosis (scleroderma). The treatment uses your own modified immune cells to try to calm the overactive immune system and slow the disease, with imaging to see where the cells go in your body.
This study looks at skin cells and immune cells in people with systemic sclerosis to better understand what drives the disease. Your participation may help researchers learn how the immune system and skin support cells change over time.
This early study uses a PET scan (a type of imaging test) to better understand lung blood-vessel disease in people who have pulmonary hypertension related to scleroderma. It may help researchers find how imaging signals relate to disease and risk.
This study uses a special PET scan called PSMA to look at inflammation in Sjögren's syndrome, comparing the results with another type of PET scan (FAPI). It may help doctors better understand the disease and find new ways to track it.
Hear when a new Systemic Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.